Report

The Saudi Arabia hemostats market was valued at USD 44.52 Million in 2024 driven by the rising number of surgeries and strong government support for healthcare modernization across the region. It is expected to grow at a CAGR of 4.10% during the forecast period of 2025-2034 and attain a market value of USD 66.54 Million by 2034. The growing adoption of minimally invasive procedures and the increasing presence of global MedTech firms are acting as emerging opportunities. These strengths and opportunities are expected to accelerate the demand for innovative hemostats throughout the forecast period.

Saudi Arabia Hemostats Market Overview

Hemostats are essential medical devices in Saudi Arabia, used to control bleeding during surgeries and trauma cases by promoting rapid hemostasis when conventional methods are insufficient. They help prevent excessive blood loss, clear the surgical field for better visibility, and support wound healing. Their use is expanding across Saudi hospitals, especially as surgical volumes and trauma cases rise. The Saudi Arabia hemostats market is expected to grow at a CAGR of 4.10% during the forecast period of 2025-2034.

Saudi Arabia Hemostats Market Growth Drivers

Rise in Surgical Procedures to Boost Market Growth

Increasing surgical volumes and government efforts to reduce wait times are key drivers expanding demand for surgical supplies. For instance, in July 2023, the Saudi Ministry of Health reported over 170,000 non-critical surgeries performed during the first half of the year, totaling approximately 177,744 surgeries nationwide. General surgery accounted for 21% of procedures, followed by obstetrics and gynecology and eye surgeries at 13% each. The ministry's initiatives to monitor and shorten waiting lists, adding around 24,000 patients monthly, enhance healthcare accessibility. This rise in surgical activity and improved service delivery will likely drive sustained growth in the Saudi hemostats market through increased consumption of bleeding-control products during surgeries.

Saudi Arabia Hemostats Market Trends

Rising surgical volumes and hospital infrastructure investments are shaping the market with advanced technology adoption.

Expansion in Hospital Infrastructure to Elevate Saudi Arabia Hemostats Market Value

The growing surgical demand from chronic-disease prevalence and Vision 2030 capital spending is intensifying the need for reliable hemostatic agents. For instance, in December 2024, the Kingdom allotted SR260 billion to health and social development, including five new hospitals adding 963 beds by 2025. Additional operating-theatre capacity will multiply bleeding-control procedures, appendectomies, trauma repairs, and cardiac surgeries, thereby driving sustained uptake of topical, mechanical, and active hemostats across public and private facilities throughout the forecast period.

Surge in Public Private Partnerships to Drive Saudi Arabia Hemostats Market Demand

Accelerating infrastructure upgrades and public-private partnerships are boosting procurement of modern surgical consumables. For instance, in April 2025, Riyadh launched 28 healthcare projects, investing over SR7 billion and delivering more than 3,000 new beds across three health clusters. Expanded specialist hospitals and upgraded emergency departments will increase complex orthopedic, cardiovascular, and oncologic surgeries, amplifying the requirement for fast-acting fibrin sealants and thrombin-based patches, thus propelling the market growth and technology adoption through 2030.

Saudi Arabia Hemostats Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

- Thrombin Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based
- Collagen Based
- Others

Market Breakup by Formulation

- Matrix and Gel Hemostats
- Sponge Hemostats
- Powder Hemostats
- Sheet and Pad
- Others

Market Breakup by Application

- Cardiovascular and Cardiothoracic
- Gynecological
- Urology
- Orthopedic Surgery
- General Surgery
- Plastic Surgery
- Ear, nose and throat (ENT), Head and Neck Surgery
- Others

Market Breakup by Indication

- Closure
- Surgery

Market Breakup by End User

- Hospitals and Clinics
- Ambulatory Surgical Centers
- Casualty Care Centers
- Others

Saudi Arabia Hemostats Market Share

General Surgery to Lead the Market Segmentation by Application

General surgery is expected to hold the largest market share due to its broad scope, encompassing appendectomies, hernia repairs, and gastrointestinal procedures, all of which frequently require hemostats to manage bleeding. As per the analysis by Expert Market Research, the global hernia repair devices market is anticipated to grow at a CAGR of 5.70% during the forecast period of 2025-2034. Compared to specialty areas like gynecology, ENT, or plastic surgery, general surgery sees significantly higher case volumes. While cardiovascular, orthopedic, and urologic procedures also contribute notably, their narrower focus limits their overall market share relative to general surgery's extensive demand across Saudi Arabia.

Leading Players in the Saudi Arabia Hemostats Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Johnson and Johnson Services Inc.

Founded in 1886 and headquartered in New Brunswick, New Jersey, Johnson & Johnson Services, Inc. is a global leader in healthcare innovation. The company offers a wide range of medical devices, pharmaceuticals, and consumer health products. In the hemostats market, J&J provides advanced surgical hemostatic agents and wound closure solutions through its Ethicon division, supporting effective bleeding control in diverse surgical procedures.

Baxter International

Baxter International, established in 1931 and based in Deerfield, Illinois, specializes in medical products that advance patient care worldwide. The company's offerings include infusion systems, renal care products, and surgical hemostats. In the hemostats segment, Baxter is known for its portfolio of fibrin sealants and topical hemostatic agents that are widely used in operating rooms to enhance surgical outcomes and reduce intraoperative blood loss.

Pfizer Inc.

Headquartered in New York City and founded in 1849, Pfizer Inc. is one of the world's largest pharmaceutical companies. While primarily recognized for its biopharmaceutical innovations, Pfizer also contributes to the hemostats market through strategic partnerships and research in surgical bleeding control. Its focus on advancing perioperative care supports broader efforts to enhance hemostasis and improve patient recovery during complex procedures.

B. Braun SE

Founded in 1839 and headquartered in Melsungen, Germany, B. Braun SE is a prominent medical and pharmaceutical device company. It offers a comprehensive range of surgical products, including hemostatic agents used to control bleeding during various procedures. The company is committed to enhancing patient safety and operational efficiency with innovative solutions in wound management and operative care across global healthcare systems.

Other key players in the market include Becton, Dickinson and Company (BD), Medtronic plc, and Stryker Corporation.

Key Questions Answered in the Saudi Arabia Hemostats Market

- What was the Saudi Arabia hemostats market value in 2024?
- What is the Saudi Arabia hemostats market forecast outlook for 2025-2034?
- What are the major factors aiding the Saudi Arabia hemostats market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Saudi Arabia hemostats market trends?
- Which type will lead the market segment?
- Which formulation will lead the market segment?
- Which application will lead the market segment?
- Which indication will lead the market segment?
- Which end user will lead the market segment?
- Who are the key players involved in the Saudi Arabia hemostats market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?